Clinical utility of genomic sequencing: a measurement toolkit
Abstract Whole-genome sequencing (WGS) is positioned to become one of the most robust strategies for achieving timely diagnosis of rare genomic diseases. Despite its favorable diagnostic performance compared to conventional testing strategies, routine use and reimbursement of WGS are hampered by inc...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-12-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-020-00164-7 |